Main Research Findings

1) Treatment with IPAM was found to reverse age-related mitochondrial decline and increase rotifer lifespan, highlighting the anti-aging potentials of the compound.

Selected Data
1) The study by Poeggeler et al investigated the biological effects of indolepropionamide (IPAM), an indole-based compound related structurally to melatonin and derived from indole-3-propionic acid (IPA). The experimental methods were designed to determine whether IPAM could protect mitochondria from age-associated dysfunction and chemically induced injury, influence mitochondrial respiratory activity, reduce oxidative damage, and extend lifespan. To address these questions, the researchers used several complementary experimental approaches. These included chemical synthesis of IPAM, high-performance liquid chromatography (HPLC) to identify and measure IPAM in rat brain tissue, experiments examining the compound’s brain bioavailability, isolation of mitochondria from young and aged animals, measurements of mitochondrial membrane potential, assays of mitochondrial respiratory-chain complexes, experiments examining interactions between IPAM and mitochondrial binding sites, antioxidant and pro-oxidant assays, measurements of oxidative DNA damage, and lifespan experiments using the bdelloid rotifer Philodina acuticornis odiosa. Melatonin and IPA were incorporated into several experiments as comparison compounds because of their structural and biological relationship to IPAM. The overall experimental strategy allowed the investigators to examine IPAM at the chemical, mitochondrial, cellular, and organismal levels [1].
The first methodological component involved the chemical synthesis and analytical identification of IPAM. The investigators synthesized the compound from indole-3-propionic acid. Initially, 30 g of indole-3-propionic acid was combined with methanesulfonic acid in ethanol and stirred for 24 hours. The resulting material was poured into water and extracted using ethyl acetate. The organic phase was washed with sodium bicarbonate and water and subsequently dried over magnesium sulfate. This procedure generated indole-3-propionic acid ethyl ester as an intermediate. A portion of the crude ester was then reacted with hydrazine in ethanol under reflux for 18 hours. Following extraction, washing, drying, and evaporation, the researchers obtained the corresponding propanoic acid hydrazide intermediate with a reported yield of approximately 93%. The hydrazide was subsequently reacted with Raney nickel catalyst in ethanol under reflux for 2.5 hours. The reaction mixture was processed by decanting and evaporation, and the remaining material was purified using silica-gel chromatography with ethyl acetate as the eluent. The final product, indole-3-propionamide, was obtained with a reported yield of approximately 96%. The purified synthetic compound served as a reference standard for subsequent analytical experiments.
The researchers next developed an HPLC procedure to detect IPAM and related indole compounds in biological samples. HPLC with fluorometric detection was performed on supernatants obtained from rat brain samples. Brain tissue was homogenized in 0.4 N perchloric acid containing EDTA and sodium metabisulfite as additives. Following preparation of the tissue samples, the investigators used a mobile phase consisting of methanol, sodium phosphate, citric acid, octanesulfonic acid, and EDTA. The mobile phase was delivered at a flow rate of 0.5 mL/minute. This chromatographic approach allowed the researchers to separate IPAM from other endogenous indole compounds and compare the resulting retention times with those of synthetic standards. Because naturally occurring IPAM was present at very low concentrations, the researchers also used a precursor-administration approach to increase the amount of IPAM available for detection. Young male Sprague-Dawley rats received 300 mg/kg of L-tryptophan, after which their brains were collected and analyzed for IPAM, melatonin, and IPA. The presence of a chromatographic peak corresponding to the synthetic IPAM standard was used to support the identification of endogenous IPAM in brain tissue [1].
A separate experiment was conducted to determine the brain bioavailability and persistence of IPAM following systemic administration. One-month-old male Sprague-Dawley rats were administered synthetic IPAM intraperitoneally at a dose of 0.5 mg/kg. Comparable groups received either melatonin or IPA at the same dose. Six animals were included for each compound. Brain samples were collected at 2, 4, and 8 hours following administration. The samples were then analyzed using the HPLC procedure described above to determine the concentration of each indole compound within the brain. This experimental design allowed the investigators to compare the ability of IPAM to enter and persist within brain tissue relative to melatonin and IPA. The use of multiple post-administration time points also provided information about the persistence of IPAM over several hours rather than limiting the analysis to a single time point [1]
The study then examined the effects of IPAM on mitochondrial membrane potential, which represents the proton motive force generated across the mitochondrial inner membrane and is an important component of ATP production. Mitochondria were isolated from rat brain using established preparation procedures. Both young and old animals were included so that age-related differences in mitochondrial energetic capacity could be assessed. The mitochondrial preparations were supplied with 6 mM malate and 6 mM glutamate to support respiration. Mitochondrial membrane potential was assessed using rhodamine 123 fluorescence. The dye was taken up by respiring mitochondria, resulting in fluorescence quenching that could be monitored in real time. Changes in rhodamine fluorescence were then used to estimate the mitochondrial membrane potential. The investigators calculated the negative mitochondrial membrane potential using the Nernst-Guggenheim equation. The effects of IPAM were compared with those of melatonin and IPA, with the compounds tested at a concentration of 10 nM. This allowed the researchers to determine whether IPAM could counteract the decline in mitochondrial energetic capacity associated with aging.
The researchers also examined whether IPAM could protect mitochondria from experimentally induced mitochondrial damage. Isolated brain mitochondria from young and old animals were exposed to several mitochondrial toxins with different mechanisms of action. The compounds examined included doxorubicin, antimycin A, and carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP). Doxorubicin and antimycin A were used to interfere with electron transport, whereas FCCP was used to dissipate the mitochondrial proton potential. The researchers measured mitochondrial membrane potential following exposure to these agents and determined whether treatment with IPAM could prevent or reduce the resulting loss of mitochondrial energetic function. This approach was particularly useful because the three toxicants disrupt mitochondrial function through different mechanisms. Consequently, if IPAM protected against all three challenges, this would support the possibility of a broader mitochondrial-stabilizing effect rather than protection against only one specific toxic pathway [1].
To investigate whether IPAM directly influenced mitochondrial oxidative phosphorylation, the investigators prepared intact mitochondria and sub-mitochondrial particles and measured the activity of specific mitochondrial respiratory complexes. Particular attention was given to complex I and complex IV of the electron-transport chain. The experimental protocols were based on established methods for evaluating mitochondrial energy metabolism. In addition to measuring complex I activity directly, the investigators used a second assay to examine activity associated with the mitochondrial iron-sulfur cluster N2 within complex I. For this analysis, mitochondrial particles from mouse brains were incubated with nitroblue tetrazolium (NBT) and superoxide dismutase under controlled incubation conditions. The reduction of NBT produced diformazan, which could be quantified spectrophotometrically. The investigators also used known inhibitors and controls to establish the specificity of the reaction. In addition, displacement experiments were performed to determine whether IPAM could interact with endogenous mitochondrial binding sites associated with complex I.
The study further investigated the antioxidant and pro-oxidant properties of IPAM. A hydroxyl-radical-generating system containing hydrogen peroxide, iron, and EDTA was used to produce oxidative radicals under controlled experimental conditions. Hydroxyl-radical production was assessed by measuring oxidation products generated from salicylate. Specifically, the researchers quantified 2,3- and 2,5-dihydroxybenzoic acid using HPLC with electrochemical detection. This method allowed the investigators to compare the ability of IPAM and related indole compounds to suppress hydroxyl-radical formation. Importantly, the experiments also evaluated whether the compounds themselves generated pro-oxidant intermediates. IPAM was compared with melatonin, IPA, and several additional indole compounds to establish whether its antioxidant activity differed from that of structurally related molecules [1].
A second oxidative-stress experiment examined whether IPAM could protect biological DNA from oxidative injury. Rat forebrain homogenates were exposed to a hydroxyl-radical-generating system containing hydrogen peroxide, ferrous sulfate, and ADP. The resulting oxidative stress was expected to damage cellular DNA. The investigators measured the formation of 8-hydroxydeoxyguanosine, an indicator of oxidative DNA damage. Different concentrations of IPAM and related indole compounds were evaluated to determine their ability to inhibit this oxidative injury. Concentration-response data were then used to calculate IC50 values, representing the concentration required to reduce oxidative DNA damage by 50%. This provided a quantitative method for comparing the protective potency of IPAM with that of melatonin and IPA.
Finally, the researchers examined whether the biochemical and mitochondrial effects of IPAM translated into changes in organismal aging and lifespan. The investigators used the bdelloid rotifer Philodina acuticornis odiosa as an experimental model of aging. Individual rotifers were maintained in isolated cultures and exposed to IPAM at concentrations of 10, 20, or 30 μM. Control animals received the vehicle treatment. Survival was followed throughout the lifespan of the animals to determine whether IPAM altered longevity. In addition to lifespan, the investigators assessed several indicators of physiological performance, including body size, number of offspring produced, and duration of the reproductive period. These measures allowed the researchers to determine whether any extension in lifespan was accompanied by changes in growth or reproductive function. The rotifer experiments therefore provided an organism-level complement to the mitochondrial studies performed in rodents [1].

Discussion
1) The study by Poeggeler et al found that indolepropionamide (IPAM) produced significant mitochondrial-protective, antioxidant, and lifespan-extending effects. The investigators first demonstrated that IPAM is naturally present in rat brain tissue and can be increased following administration of its metabolic precursor, L-tryptophan. Although endogenous IPAM concentrations were initially extremely low, treatment with 300 mg/kg L-tryptophan allowed the compound to be detected reliably. Brain concentrations after precursor administration were approximately 34,669 pg/mg protein for IPAM, 713,632 pg/mg protein for melatonin, and 281,614 pg/mg protein for indole-3-propionic acid (IPA). The chromatographic characteristics of the biological IPAM signal corresponded with those of the synthetic reference compound, supporting the identification of IPAM as an endogenous brain indole. These findings established that IPAM can occur naturally within the brain and may be produced through tryptophan-associated metabolic pathways [1].
The investigators next evaluated the distribution and persistence of IPAM within the brain following systemic administration. After rats received 0.5 mg/kg IPAM intraperitoneally, the compound reached substantially higher brain concentrations than either melatonin or IPA. IPAM concentrations were approximately 691 ± 23 pg/mg protein after two hours, 562 ± 13 pg/mg protein after four hours, and 361 ± 12 pg/mg protein after eight hours. In comparison, melatonin and IPA remained at relatively low or barely detectable concentrations. The continued detection of IPAM eight hours after administration demonstrated that the compound could cross into brain tissue and remain present for a prolonged period. The researchers suggested that the chemical structure of IPAM may explain this improved brain penetration. Unlike IPA, which contains a negatively charged carboxyl group under physiological conditions, IPAM has an amide group and greater lipophilic characteristics that may facilitate membrane permeability.
The mitochondrial experiments showed that IPAM improved mitochondrial energetic function, particularly in preparations obtained from aged animals. Older mitochondria demonstrated a reduction in membrane potential compared with mitochondria isolated from younger animals, consistent with age-associated mitochondrial impairment. Exposure to IPAM increased mitochondrial membrane potential in both young and aged preparations. Melatonin and IPA also produced improvements, but IPAM demonstrated the strongest effect under the experimental conditions. Because mitochondrial membrane potential provides the electrochemical gradient necessary for ATP synthesis, the ability of IPAM to preserve this potential suggests that the compound can support mitochondrial energy production. The results therefore provided evidence that IPAM may counteract some of the functional deterioration that occurs in mitochondria during aging [1].
IPAM also demonstrated considerable protection against experimentally induced mitochondrial damage. The investigators exposed isolated mitochondria to doxorubicin, antimycin A, and FCCP, all of which produced significant reductions in mitochondrial membrane potential. When IPAM was administered alongside these mitochondrial stressors, the decline in membrane potential was substantially reduced. The protective response was observed in mitochondria from both young and aged animals. IPAM was particularly effective against the mitochondrial depolarization caused by doxorubicin and antimycin A, while it also significantly reduced the effects of FCCP. Because these agents interfere with mitochondrial function through different mechanisms, the findings suggested that IPAM may provide relatively broad mitochondrial protection rather than acting against only one specific toxic pathway.
Additional experiments indicated that IPAM influenced the mitochondrial electron-transport system. Treatment with IPAM increased the activity of respiratory-chain complex I and complex IV, whereas no significant effect was reported for complex II–III. The increase in complex I activity was independently verified through an NBT reduction assay targeting the N2 iron-sulfur center of complex I. This independent measurement strengthened the evidence that IPAM directly influences complex I function. The investigators also observed displacement of known ligands from mitochondrial binding sites, providing additional support for the possibility that IPAM interacts with mitochondrial components. Since complex I plays an important role in electron transport and oxidative phosphorylation, increased activity at this site could improve the efficiency of mitochondrial respiration. It could also potentially reduce electron leakage, which is an important contributor to mitochondrial ROS production [1].

Figure 1: Changes in the activity levels of complex I, complex IV, and the N2 cluster
The antioxidant experiments demonstrated that IPAM was effective at limiting hydroxyl-radical formation and oxidative damage. In a chemical system designed to generate hydroxyl radicals, IPAM exhibited strong radical-scavenging activity. Importantly, it did not display the pro-oxidant behavior observed with several other indole compounds tested in the study. Serotonin, 6-hydroxymelatonin, and 5-methoxyindoleacetic acid increased hydroxyl-radical formation under the experimental conditions, whereas IPAM did not produce detectable pro-oxidant activity. IPA similarly lacked detectable pro-oxidant effects. These findings indicated that IPAM could suppress oxidative reactions without simultaneously generating additional reactive species, which may contribute to its overall protective profile.
The researchers further demonstrated that IPAM could protect DNA from oxidative injury. In rat forebrain homogenates exposed to a hydroxyl-radical-generating system, IPAM reduced the formation of 8-hydroxydeoxyguanosine, a biomarker of oxidative DNA damage. IPAM had an IC50 of approximately 0.18 ± 0.03 mM, compared with 1.46 ± 0.16 mM for melatonin and 7.46 ± 0.80 mM for IPA. The substantially lower IC50 indicated that IPAM was more potent than either comparison compound in preventing oxidative DNA damage under the conditions of the assay. These results provided additional evidence that IPAM’s biological effects extended beyond mitochondrial membrane stabilization and included protection of cellular macromolecules from free-radical-mediated injury [1].
The study’s most substantial organism-level findings came from experiments using the bdelloid rotifer Philodina acuticornis odiosa. Treatment with IPAM produced a strong, concentration-dependent extension of lifespan. Control rotifers had an average lifespan of approximately 24.6 ± 1.8 days. Treatment with 10 μM IPAM increased mean lifespan to 58.5 ± 3.3 days, while 20 μM increased it to 81.1 ± 3.7 days. The highest concentration, 30 μM, increased mean lifespan to approximately 90.5 ± 3.8 days. Consequently, the highest concentration produced a lifespan more than three times longer than that of untreated animals. The investigators reported statistically significant effects across the treatment groups, indicating that the observed longevity response was unlikely to be attributable to random variation [1].
IPAM treatment was also associated with increased body size in the rotifer model. After 15 days of exposure to 30 μM IPAM, treated rotifers had an average length of approximately 575 ± 6 μm, compared with approximately 390 ± 5 μm among control animals. This represented a substantial increase in body size. The finding was particularly notable because longevity-enhancing interventions sometimes involve reduced growth or developmental tradeoffs. In this experiment, however, the increase in lifespan occurred alongside increased body size, suggesting that IPAM did not simply extend survival by reducing metabolic or developmental activity. Instead, the compound appeared to support several aspects of physiological function in the rotifers.
The investigators also observed marked improvements in reproductive performance. Control rotifers produced approximately 16 ± 1 offspring over their lifetime, whereas those treated with 30 μM IPAM produced approximately 55 ± 1 offspring. The 10 and 20 μM concentrations also increased reproductive output, resulting in approximately 52 and 53 offspring, respectively. IPAM additionally prolonged the reproductive period. Control animals remained fertile for approximately 5 ± 1 days, while animals receiving 30 μM IPAM remained fertile for approximately 18 ± 1 days. The 10 and 20 μM treatments extended reproductive activity to approximately 13 and 16 days, respectively. Therefore, IPAM not only extended overall survival but also maintained reproductive capability for a longer portion of the animals’ lives [1].
Overall, the findings demonstrate that IPAM had multiple protective effects extending from mitochondrial function to whole-organism longevity. The compound was detected as an endogenous brain indole and demonstrated greater brain persistence than melatonin and IPA following systemic administration. At the mitochondrial level, IPAM improved membrane potential, protected against several different mitochondrial toxins, and increased the activity of complexes I and IV. The compound also exhibited strong antioxidant activity and reduced oxidative DNA damage, while avoiding the pro-oxidant effects observed with several related indoles. In the rotifer model, IPAM dramatically extended lifespan while simultaneously increasing body size, offspring production, and reproductive duration [1].

Disclaimer

**LAB USE ONLY**
*This information is for educational purposes only and does not constitute medical advice. THE PRODUCTS DESCRIBED HEREIN ARE FOR RESEARCH USE ONLY. All clinical research must be conducted with oversight from the appropriate Institutional Review Board (IRB). All preclinical research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC) following the guidelines of the Animal Welfare Act (AWA).

Citations

[1] Poeggeler B, Sambamurti K, Siedlak SL, Perry G, Smith MA, Pappolla MA. A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan. PLoS One. 2010;5(4):e10206. Published 2010 Apr 21. doi:10.1371/journal.pone.0010206

Indolepropionamide (IPAM) is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.